Gimv
Gimv is a European, publicly listed investment company focused on growth private equity. It operates five sector-focused investment platforms (Consumer, Healthcare, Life Sciences, Smart Industries, Sustainable Cities) and manages a diversified portfolio of companies across Europe. Reported key figures include a portfolio value of around EUR 1.6 billion, approximately 61 portfolio companies, combined turnover of EUR 4.5 billion and more than 20,000 professionals in portfolio companies. The firm targets small and mid-sized companies (typical capital need up to EUR 150 million) mainly located in the Benelux countries, France, Germany, Austria and Switzerland. Gimv's shares are listed on Euronext Brussels (ISIN: BE0003699130); market capitalisation was reported as EUR 1,658,332,531.65 (28/11/2025).
Services
Growth equity investments
Provision of growth capital and structured investments for small and mid-sized companies across five sector platforms.
Active portfolio development
Operational support for portfolio companies including financial controls, KPI implementation, management development, production automation and digitalization.
Capital markets and financing solutions
Issuance and management of debt instruments and development of sustainable finance frameworks to support corporate funding needs.
Growth equity investments
Provision of growth capital and structured investments for small and mid-sized companies across five sector platforms.
Active portfolio development
Operational support for portfolio companies including financial controls, KPI implementation, management development, production automation and digitalization.
Capital markets and financing solutions
Issuance and management of debt instruments and development of sustainable finance frameworks to support corporate funding needs.
Expertise Areas
- Growth-stage private equity
- Sector-focused investing (Consumer, Healthcare, Life Sciences, Smart Industries, Sustainable Cities)
- Active portfolio value creation
- International expansion and market-entry support
- Healthcare and medtech investing
- Life-sciences and clinical development investing
- Digital transformation and software platform scaling
- Sustainable investing and ESG integration
Key Technologies
- Digital health platforms
- Medical devices
- Biopharmaceutical development
- Radiopharmaceuticals
- Antibody-drug conjugates (ADC)
- Neurostimulation therapies
- At-home polysomnography (sleep study) devices
- Industrial automation and mechatronics